Covidien Opens R&D Facility in China

Covidien has opened a new $45 million R&D center in Shanghai, China. The center has two core focus areas: design of tailored products and discovery of breakthrough platforms in medical technology.

Covidien has announced the opening of its China Technology Center (CTC) R&D facility in Shanghai, with a total investment of $45 million over a three-year period.

The facility spans more than 100,000 square feet (9,290 square meters), houses 17 laboratories, and has state-of-the-art surgical and simulation suites that enable healthcare professionals to be actively involved in the medical device design and development process.

The CTC has two core focus areas: design of tailored products, to identify and develop products that are customized to meet the needs of China and other emerging markets; and discovery of breakthrough platforms in medical technology, to utilize the skill sets and expertise of employees in Asia.